Literature DB >> 24591106

MRI and MRA of spinal cord arteriovenous shunts.

Stéphanie Condette-Auliac1, Anne Boulin, Luca Roccatagliata, Oguzhan Coskun, Stéphanie Guieu, Pierre Guedin, Georges Rodesch.   

Abstract

The purpose of this review is to describe the diagnostic criteria for spinal cord arteriovenous shunts (SCAVSs) when using magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA), and to discuss the extent to which the different MRI and MRA sequences and technical parameters provide the information that is required to diagnose these lesions properly. SCAVSs are divided into four groups according to location (paraspinal, epidural, dural, or intradural) and type (fistula or nidus); each type of lesion is described. SCAVSs are responsible for neurological symptoms due to spinal cord or nerve root involvement. MRI is usually the first examination performed when a spinal cord lesion is suspected. Recognition of the image characteristics of vascular lesions is mandatory if useful sequences are to be performed-especially MRA sequences. Because the treatment of SCAVSs relies mainly on endovascular therapies, MRI and MRA help with the planning of the angiographic procedure. We explain the choice of MRA sequences and parameters, the advantages and pitfalls to be aware of in order to obtain the best visualization, and the analysis of each lesion.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  MR angiography; MRA; MRI; spinal cord arteriovenous malformation; spinal cord arteriovenous shunt

Mesh:

Year:  2014        PMID: 24591106     DOI: 10.1002/jmri.24591

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  8 in total

1.  Reliability and accuracy of time-resolved contrast-enhanced magnetic resonance angiography in hypervascular spinal metastases prior embolization.

Authors:  Kévin Premat; Eimad Shotar; Robert Burns; Natalia Shor; Gauthier Eloy; Évelyne Cormier; Mehdi Drir; Laetitia Morardet; Stéphanie Lenck; Nader Sourour; Jacques Chiras; Didier Dormont; Raphaël Bonaccorsi; Frédéric Clarençon
Journal:  Eur Radiol       Date:  2021-01-15       Impact factor: 5.315

2.  Study and therapeutic progress on spinal cord perimedullary arteriovenous fistulas.

Authors:  Tiefeng Ji; Yunbao Guo; Lei Shi; Jinlu Yu
Journal:  Biomed Rep       Date:  2017-07-25

3.  16 SETTEMBRE 2015 - Sala Vesuvio - ore 15:30 - 17:00 DISCUTIAMONE INSIEME: PRESENTAZIONE DI CASI CLINICI.

Authors: 
Journal:  Neuroradiol J       Date:  2015-09

4.  First-Pass Contrast-Enhanced MR Angiography in Evaluation of Treated Spinal Arteriovenous Fistulas: Is Catheter Angiography Necessary?

Authors:  S Mathur; S P Symons; T J Huynh; T R Marotta; R I Aviv; A Bharatha
Journal:  AJNR Am J Neuroradiol       Date:  2016-11-03       Impact factor: 3.825

5.  Radiculo-pial spinal arteriovenous fistulas treated with coils: Report of two cases.

Authors:  André Lima Batista; Diego Gutierrez Romero; Jean-Christophe Gentric; Alain Weill; Jean Raymond; Daniel Roy
Journal:  Interv Neuroradiol       Date:  2015-06-25       Impact factor: 1.610

6.  Spinal cord arteriovenous shunts of the ventral (anterior) sulcus: anatomical, clinical, and therapeutic considerations.

Authors:  Luca Roccatagliata; Shushi Kominami; Antonin Krajina; Robin Sellar; Michael Soderman; René Van den Berg; Hubert Desal; Stephanie Condette-Auliac; Georges Rodesch
Journal:  Neuroradiology       Date:  2017-03-01       Impact factor: 2.804

7.  Clinical Outcomes of Patients with Delayed Diagnosis of Spinal Dural Arteriovenous Fistulas.

Authors:  W Brinjikji; D M Nasr; J M Morris; A A Rabinstein; G Lanzino
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-03       Impact factor: 3.825

Review 8.  Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines.

Authors:  Massimo Filippi; Paolo Preziosa; Brenda L Banwell; Frederik Barkhof; Olga Ciccarelli; Nicola De Stefano; Jeroen J G Geurts; Friedemann Paul; Daniel S Reich; Ahmed T Toosy; Anthony Traboulsee; Mike P Wattjes; Tarek A Yousry; Achim Gass; Catherine Lubetzki; Brian G Weinshenker; Maria A Rocca
Journal:  Brain       Date:  2019-07-01       Impact factor: 13.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.